US Patent Issued to Wyvern Pharmaceuticals on Nov. 25 for "Composition for regulating production of interfering ribonucleic acid" (Canadian Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,123, issued on Nov. 25, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada).

"Composition for regulating production of interfering ribonucleic acid" was invented by Bradley G. Thompson (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The embodiments of the present disclosure relate to one or more compositions or methods that upregulate the production of one or more sequences of micro-interfering ribonucleic acid (miRNA). The sequences of miRNA may be complimentary to a sequence of target messenger RNA (mRNA) that encodes for translation of a target biomolecule, such as CXCR1. The miRNA can cause the target mRNA to be degrade...